VivoSeq
Psychiatry

Drug Abuse

0

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Drug Abuse is an early-stage landscape with 0 programs across 2 companies. The most active players are Pain Therapeutics, Takeda.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pain Therapeutics

0 programs

PreclinicalTakeda logo

Takeda

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

14

clinical trials

Completed9 · 64%
Recruiting2 · 14%
Withdrawn1 · 7%
Unknown status1 · 7%
Not yet recruiting1 · 7%

Clinical Trials

Trial Activity

14 trials

Opioid/Benzodiazepine Polydrug Abuse: Aim 3
Recruiting·WWayne State University·Phase 2·NCT05006079·24 enrolled
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Recruiting·National Institute on Drug Abuse (NIDA)·Preclinical·NCT01036581·1,000 enrolled
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
Not yet recruiting·UUniversity of Sao Paulo·Preclinical·NCT07039539·32 enrolled
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
Completed·PPain Therapeutics·Phase 2·NCT00734461·14 enrolled
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse
Completed·Takeda logoTakeda·Phase 2·NCT00671632·14 enrolled
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Completed·UUniversity of Kansas·Phase 2·NCT00000217
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
Completed·UUniversité de Montréal·Phase 4·NCT00295412
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
Completed·NNew York State Psychiatric Institute·Phase 1·NCT03679949·26 enrolled
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
Completed·National Institute on Drug Abuse (NIDA)·Phase 1·NCT00292123·200 enrolled
HIV Risk Reduction and Drug Abuse Treatment in Malaysia
Completed·YYale University·Phase 2·NCT00383045·180 enrolled
Medications Development for Drug Abuse Disorders
Completed·JJohns Hopkins University·Phase 1/2·NCT01188421·106 enrolled
Cognitive Task Development and Implementation for Functional MRI Studies
Completed·National Institute on Drug Abuse (NIDA)·N/A·NCT01036685·525 enrolled
HIV Risk Reduction and Drug Abuse Treatment in Iran
Withdrawn·YYale University·Phase 2·NCT00398008
Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse
Unknown status·CCentro Universitario de Tonalá·N/A·NCT05712044·45 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)